Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Watchlist
Price: 3.43 USD -2% Market Closed
Market Cap: 4.9B USD

Intrinsic Value

The intrinsic value of one T14 stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.43 USD, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

T14 Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Intrinsic Value History
Dive into the past to invest in the future

T14 looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether T14 usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about T14?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is T14 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Explain Valuation
Compare T14 to

Fundamental Analysis

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Current Assets 7B
Receivables 1.6B
Other Current Assets 5.3B
Non-Current Assets 4.6B
Long-Term Investments 1.3B
PP&E 1.2B
Intangibles 328m
Other Non-Current Assets 1.8B
Current Liabilities 2.5B
Accounts Payable 200m
Accrued Liabilities 269m
Short-Term Debt 15m
Other Current Liabilities 2B
Non-Current Liabilities 99m
Long-Term Debt 34m
Other Non-Current Liabilities 65m
Efficiency

Free Cash Flow Analysis
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Revenue
5.4B CNY
Cost of Revenue
-1.9B CNY
Gross Profit
3.4B CNY
Operating Expenses
-2.7B CNY
Operating Income
788.6m CNY
Other Expenses
2.8B CNY
Net Income
3.6B CNY
Fundamental Scores

T14 Profitability Score
Profitability Due Diligence

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROE
Exceptional Net Margin
ROE is Increasing
Positive 3Y Average ROE
hidden
Profitability
Score

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

T14 Solvency Score
Solvency Due Diligence

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

T14 Price Targets Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

There are no price targets for T14.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one T14 stock?

The intrinsic value of one T14 stock under the Base Case scenario is hidden USD.

Is T14 stock undervalued or overvalued?

Compared to the current market price of 3.43 USD, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is hidden .

Back to Top